That ressource is reserved for health professionals

This space contains information on medical devices, the use of which is reserved for healthcare professionals. In application of the law of December 29, 2011 relating to the strengthening of health security, I certify that I am a health professional and therefore be authorized to access this information.

I am a healthcare professional



Close menu



Concizumab – Labelled (Arg,Lys) 13C15N


Quantification of Concizumab

Specific labelling

Arginine: 13C6,15N4>99%

Lysine: 13C6,15N2, >99%


Concizumab is an anti-tissue factor pathway inhibitor (TFPI) antibody in development for once-daily prophylactic treatment (regular treatment to prevent prolonged and spontaneous bleeding) by administration under-the-skin for all types of haemophilia.

This product is for research use only and is not intended for diagnostic or therapeutic use.